老年人心肌梗塞后心室隔膜缺陷的治疗考虑 - 一个教育性演讲
Omar Julián Chavarro-Alfonso1, Rene Ricardo Díaz1, Efraín Alonso Gómez2
1Cardiac Critical Care Department, Fundación Clínica Shaio, Bogotá D.C., Colombia.
Brazilian journal of cardiovascular surgery
|July 2, 2025
概括
心肌梗塞后心室隔膜缺陷是一种罕见但严重的并发症. 及时干预,包括使用大动脉内气球,可以稳定患者进行手术并改善结果.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 心肌梗塞后心室隔膜缺陷 (VSD) 是一种罕见的并发症,在没有手术干预的情况下预后不佳.
- 一名80岁的女性出现了ST升高心肌梗塞 (STEMI),并由VSD和心脏性休克复杂化.
研究的目的:
- 报告心肌梗塞后的VSD病例.
- 为了突出一个危急病患者的管理.
主要方法:
- 一个80岁的女性患有下级STEMI和VSD的案例报告.
- 使用大动脉内气球 (IABP) 进行血液动力稳定.
主要成果:
- 患者的情况迅速恶化为心脏性休克.
- IABP插入改善了血液动力学状况,使得手术前稳定.
结论:
- 心室隔膜缺陷是心肌梗塞的危及生命的并发症.
- 动脉内气球可以成为血液动力学不稳定的患者手术修复的关键桥梁.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


